Last updated: October 25, 2026

Application No. 18/291,631

NOVEL APPLICATIONS FOR OXAZABOROLIDINES AND NEW METHODS OF MANUFACTURE THEREOF

Final Rejection

Filed

Jan 24, 2024

Priority

Aug 03, 2021 — GB 2111203.2 +1 more

Examiner

MARTIN, KEVIN STEPHEN

Art Unit

1624

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Pathway Intermediates Limited

OA Round

2 (Final)

Interview Optional

— +23.3% interview lift. Examiner has a relatively high allowance rate (77%); +23.3% interview lift. A written response may suffice.

Based on 159 resolved cases, 2023–2026

Examiner Intelligence

MARTIN, KEVIN STEPHEN View full profile →

Grants 77% — above average

Career Allowance Rate

123 granted / 159 resolved

+17.4% vs TC avg

Strong +23% interview lift

Without

With

+23.3%

Interview Lift

resolved cases with interview

Typical timeline

3y 5m

Avg Prosecution

53 currently pending

Career history

197

Total Applications

across all art units

Statute-Specific Performance

§101

1.3%

-38.7% vs TC avg

§103

25.0%

-15.0% vs TC avg

§102

16.9%

-23.1% vs TC avg

§112

41.3%

+1.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 159 resolved cases

Prosecution Timeline

Jan 24, 2024

Application Filed

Jun 03, 2026

Non-Final Rejection mailed

Aug 28, 2026

Response Filed

Sep 22, 2026

Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/635,983

Patent 12758629

N-ARYL SULFONAMIDE DERIVATIVES AS VACCINE ADJUVANT

4y 8m to grant Granted Oct 13, 2026

17/614,956

Patent 12746239

COMPOSITIONS AND METHODS COMPRISING ENDOTHELIN A RECEPTOR ANTAGONISTS AND ANDROGEN THERAPIES

4y 10m to grant Granted Sep 29, 2026

17/909,260

Patent 12747214

IMIDAZOLE-BASED SYNTHETIC LIPIDOIDS FOR IN VIVO MRNA DELIVERY INTO IMMUNE CELLS

4y 0m to grant Granted Sep 29, 2026

17/919,402

Patent 12746241

SOLID PHARMACEUTICAL PREPARATION, PREPARATION METHOD THEREFOR AND USE THEREOF

3y 11m to grant Granted Sep 29, 2026

18/249,022

Patent 12746222

IMPLANTABLE DEPOTS FOR LOCALIZED, SUSTAINED, CONTROLLED RELEASE OF THERAPEUTIC AGENTS TO TREAT CANCER AND RELATED CONDITIONS

3y 5m to grant Granted Sep 29, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4

Expected OA Rounds

77%

Grant Probability

99%

With Interview (+23.3%)

3y 5m (~8m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 159 resolved cases by this examiner. Grant probability derived from career allowance rate.